| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,302 |
2,852 |
$151K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
612 |
494 |
$32K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
288 |
274 |
$20K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
536 |
479 |
$12K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
214 |
193 |
$6K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
800 |
615 |
$5K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
378 |
301 |
$3K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
65 |
61 |
$3K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
156 |
140 |
$3K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
174 |
136 |
$3K |
| 36415 |
Collection of venous blood by venipuncture |
173 |
148 |
$264.07 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
148 |
128 |
$121.97 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
18 |
17 |
$86.66 |
| 81003 |
|
28 |
26 |
$35.90 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
31 |
25 |
$30.49 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
275 |
240 |
$25.69 |